Description: NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
Home Page: www.netramark.com
1655 Dupont Street
Toronto,
ON
M6P 3T1
Canada
Phone:
403-681-2549
Officers
| Name | Title |
|---|---|
| Mr. George Achilleos | CEO & Director |
| Mr. Josh Spiegel | President |
| Mr. Daniel Gallucci | Founder, Chief Performance Officer & Director |
| Dr. Joseph Geraci Ph.D. | Founder, Chief Scientific & Technical Officer and Director |
| Mr. Swapan Kakumanu ACA, ACWA, CGA | Chief Financial Officer |
| Ms. Jaime Hackett | Vice President of Marketing |
| Dr. Luca Pani M.D. | Chief Innovation & Regulatory Officer and Chief Medical Advisor |
| Dr. Kaveh Kavoosi | Head of Progressive Medicine |
| Dr. Larry Alphs | Chief Medical Officer & Member of Advisory Board |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Technology |
| GIC Sub-Industry: | Health Care Technology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 251.2826 |
| Price-to-Sales TTM: | 159.3457 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |